Elbonix 50 MG (Eltrombopag)
Elbonix (Eltrombopag) 50 mg treats low platelet counts in adults with chronic immune thrombocytopenia (ITP) unresponsive to other therapies, helping reduce bruising and bleeding risks. Approved in 2012, it’s also used in chronic hepatitis C patients to maintain platelet levels during interferon-based treatment. 
0 Commentaires 0 Parts 1KB Vue 0 Aperçu
Commandité
Commandité
Commandité
google-site-verification: google037b30823fc02426.html